FDA Drug Application (018723) for DEPAKOTE by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number018723
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
DosageEQ 250MG VALPROIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDEPAKOTE
Active IngredientDIVALPROEX SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIVALPROEX SODIUM4


Back to FDA Applications sponsored by ABBVIE